title: Angiotensin II: a hormone that affects lipid metabolism in adipose tissue.
abstract: BACKGROUND
  Alterations in adipose tissue lipolysis may contribute to the pathophysiology of obesity and insulin resistance. We examined the effects of angiotensin II (Ang II) on abdominal subcutaneous adipose tissue lipolysis in humans.
  
  
  RESULTS
  First, adipocytes obtained from nine normal weight and seven obese subjects were stimulated with Ang II (10(-14)-10(-6) M). Glycerol concentration in the medium, used as an indicator of adipocyte lipolysis, was significantly reduced (approximately 20%) after Ang II stimulation in adipocytes from normal weight (P=0.04) and obese subjects (P<0.001). Based on these observations, adipocytes of seven additional obese subjects were stimulated with lower doses of Ang II (10(-17)-10(-6) M) in the presence and absence of Ang II type 1 (AT(1)) receptor blockade. Lipolysis was dose dependently inhibited by approximately 20 to 25% after Ang II stimulation (P=0.001). AT(1) receptor blockade completely abolished the Ang II-induced effects (P=0.35).
  
  
  CONCLUSIONS
  Ang II directly inhibits abdominal subcutaneous adipocyte lipolysis in normal weight and obese subjects via the AT(1) receptor.
authors.affiliation: Department of Human Biology, Nutrition and Toxicology Research Institute Maastricht (NUTRIM), Maastricht University, Maastricht, The Netherlands. G.Goossens@hb.unimaas.nl
authors.forename: G H
authors.initials: GH
authors.lastname: Goossens
authors.forename: E E
authors.initials: EE
authors.lastname: Blaak
authors.forename: P
authors.initials: P
authors.lastname: Arner
authors.forename: W H M
authors.initials: WH
authors.lastname: Saris
authors.forename: M A
authors.initials: MA
authors.lastname: van Baak
mesh_terms: D017667:Adipocytes / Q000187:drug effects / Q000378:metabolism; D000804:Angiotensin II / Q000494:pharmacology* / Q000502:physiology; D047228:Angiotensin II Type 1 Receptor Blockers / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D006801:Humans; D050356:Lipid Metabolism / Q000187:drug effects* / Q000502:physiology; D008066:Lipolysis / Q000187:drug effects; D008297:Male; D008875:Middle Aged; D009765:Obesity / Q000378:metabolism* / Q000503:physiopathology; D044140:Receptor, Angiotensin, Type 1 / Q000502:physiology; D050507:Subcutaneous Fat, Abdominal / Q000187:drug effects* / Q000378:metabolism
chemical_list: D047228:Angiotensin II Type 1 Receptor Blockers; D044140:Receptor, Angiotensin, Type 1; D000804:Angiotensin II